mitomycin has been researched along with vindesine in 164 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (25.00) | 18.7374 |
| 1990's | 81 (49.39) | 18.2507 |
| 2000's | 35 (21.34) | 29.6817 |
| 2010's | 7 (4.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Hasegawa, K; Kuriyama, T; Motomiya, M; Niitani, H; Ota, K; Takada, M; Tominaga, K | 1 |
| Asselain, B; Blaszka, B; Brunin, F; Jaulerry, C; Jouve, M; Mosseri, V; Point, D; Rodriguez, J; Validire, P; Zafrani, B | 1 |
| Airoma, G; Bianco, AR; Gridelli, C; Incoronato, P; Palazzolo, G; Pepe, R; Rossi, A | 2 |
| Hirabayashi, M; Kawakami, K; Kuno, K; Mishima, M; Nakagawa, M; Tanaka, Y; Yoshida, H | 1 |
| Sculier, JP | 1 |
| Fukuoka, M; Kudoh, S; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Takada, M; Takifuji, N | 1 |
| Karato, A; Miya, T; Saijo, N; Sasaki, Y | 1 |
| Lee, YK; Shin, DM | 1 |
| Gianoutsos, P; Grygiel, J; Lee, JH; McCaughan, BC; McNeil, E; Raghavan, D; Stockler, M | 1 |
| Balli, M; Bonciarelli, G; Jirillo, A; Lonardi, F; Pavanato, G | 1 |
| Adenis, A; Bonneterre, J; Degardin, M; Demaille, A; Hecquet, B; Pion, JM | 1 |
| Bonichon, F; Chauvergne, J; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
| Kanamaru, R; Kikuchi, H | 1 |
| Kajita, M; Niimi, T; Saito, H | 1 |
| Hara, N; Ohta, M | 1 |
| Airoma, G; Garufi, C; Gebbia, V; Gentile, M; Gridelli, C; Iacobelli, S; Palmeri, S; Palmieri, G; Pepe, R; Russo, A | 1 |
| Gatzemeier, U; Heckmayr, M; Hossfeld, DK; Kaukel, E; Koschel, G; Neuhauss, R | 2 |
| Aso, H; Hara, N; Ichinose, Y; Kuda, T; Motohiro, A; Ohta, M | 1 |
| D'Alessandro, N; Gebbia, N; Gebbia, V; Palmeri, S; Rausa, L; Russo, A | 1 |
| Cavalli, F; Gatzemeier, U; Häussinger, K; Kaukel, E; Koschel, G; Martinelli, G; Neuhauss, R; von Pawel, J | 1 |
| Eguchi, K; Kojima, A; Miya, T; Ohe, Y; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Ito, K; Kuramitsu, T; Matsumoto, T; Nakaki, H; Nakamura, H; Nishikawa, H; Suda, H; Suga, K; Tanaka, N; Uchisako, H | 1 |
| Esato, K; Hirayama, T; Nawata, S; Suzuki, K; Takahashi, M | 1 |
| Avril, A; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
| Chapman, D; Fiore, J; Kambhu, SA; Kelsen, DP; Niedzwiecki, D; Rosenbluth, R; Vinciguerra, V | 1 |
| Abad-Esteve, A; Barnadas, A; Carles, J; Culubret, M; Fernandez, C; Moreno, I; Ribelles, N; Rosell, R | 1 |
| Fukuoka, M; Kubota, K; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N | 1 |
| Koga, K; Minoda, S | 1 |
| Fukuoka, M; Furuse, K; Kawahara, M; Masuda, N; Matsui, K; Negoro, S; Takada, M; Takifuji, N | 1 |
| Häussinger, K; Jungbluth, H; Krieger, H; Laumen, R; Otto, M; von Pawel, J | 1 |
| Adachi, S; Hayashi, Y; Ito, G; Kato, M; Matsuura, T; Takeuchi, T; Yamada, Y; Yamamoto, K | 1 |
| Hattori, T; Hirai, T; Miyoshi, Y; Niimoto, M; Ohtagaki, S; Yoshihara, T | 1 |
| Fujita, J; Saijo, N | 1 |
| Geneix, A; Malet, P; Perissel, B; Turchini, JP; Turchini, MF | 1 |
| Breau, JL; Clavier, J; Gres, JJ; Israël, L; Lerebours-Pigeonnière, G; Morère, JF; Nouvet, G; Raut, Y; Zabbe, C | 1 |
| Ikeda, K; Inada, K; Ishida, K; Mori, S; Satoh, M; Terashima, M; Yoshida, H; Yoshida, M | 1 |
| Blair, AH; Ghose, T | 1 |
| Inoue, F; Mimura, H; Miyake, M; Mori, T; Orita, K; Takeda, I; Tanaka, N | 1 |
| Fujiwara, K; Jyojya, I; Mitsuhata, N; Miyake, M; Ono, T; Sato, T | 1 |
| Kellokumpu-Lehtinen, P | 1 |
| Einhorn, L; Luedke, DW; Luedke, SL; Lyss, AP; Raney, M | 1 |
| Hayashi, H; Hotta, T; Kanatsuna, T; Kondoh, M; Nakai, M; Nakano, K; Onodera, H; Sawada, M; Setoguchi, J; Sigeta, M | 1 |
| Fukuhara, H; Oomura, M; Sasaki, H | 1 |
| Dohi, Y; Houya, I; Kaneko, K; Kimura, I; Kiuchi, H; Kuramitsu, K; Nagata, M; Sakamoto, Y; Yamamoto, K | 1 |
| Eguchi, K; Fujiwara, Y; Kojima, A; Minato, K; Nakagawa, K; Nakajima, T; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Fujii, M; Kimura, M; Kiura, K; Okabe, K; Toki, H | 1 |
| Bains, MS; Burt, ME; Gralla, RJ; Kaiser, LR; Kris, MG; Martini, N; McCormack, PM; Zaman, MB | 1 |
| Belpomme, D; Cour, V; Gisselbrecht, C; Godeffroy, W; Le Rol, A; Maral, J; Marty, M; Mignot, L | 1 |
| Fujita, F; Fujita, M; Inaba, H; Sakamoto, Y; Shimozuma, K; Taguchi, T | 1 |
| Fujita, F; Fujita, M; Inaba, H; Sakamoto, Y; Shimozuma, K; Taguchi, T; Yamauchi, T | 1 |
| Falkson, CI; Falkson, G; Falkson, HC | 1 |
| Buzzi, F; Crino, L; Davis, S; Di Costanzo, F; Gori, S; Grignani, F; Tonato, M | 1 |
| Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R | 1 |
| Hain, E; Kaukel, E; Koschel, G | 1 |
| Chauvergne, J; David, M; Durand, M; Hoerni, B; Mauriac, L | 1 |
| Drasga, R; Einhorn, LH; Fisher, W; Gabrys, T; Loehrer, PJ; Meyers, S; Nattan, SR; Songer, J; Williams, SD; Woodburn, R | 1 |
| Fujieda, K; Ibe, Y; Ito, T; Morinari, H; Naito, S; Okubo, S | 1 |
| Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N; Tsubura, E | 1 |
| Creech, RH; Ettinger, DS; Finkelstein, DM; Joss, RA; Mason, BA; Ruckdeschel, JC; Vogl, S | 1 |
| Burke, MT; Cibas, IR; Fiore, JJ; Gralla, RJ; Heelan, RT; Kelsen, DP; Kris, MG; O'Connell, JP; Wertheim, MS | 1 |
| Ahmann, FR; Miller, TP; Rodney, SR; Vance, RB | 1 |
| Daughaday, C; Harrison, B; Luedke, D; Luedke, S; Martello, O; McLaughlin, TT; Reed, G | 1 |
| Eguchi, K; Fujita, J; Futami, H; Kimata, M; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Takahashi, K; Tominaga, K | 1 |
| Jones, WG | 1 |
| Klastersky, J; Sculier, JP | 1 |
| Eguchi, K; Ohkura, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Takahashi, K; Tominaga, K | 1 |
| Kelsen, D | 1 |
| Eguchi, K; Iwashita, K; Niitani, H; Saijo, N; Shimabukuro, Z; Shimizu, E; Shinkai, T; Tominaga, K | 1 |
| Schroeder, FH | 1 |
| Bakowski, MT; Crouch, JC | 1 |
| Brooks, RJ; Garewal, HS; Jones, SE; Miller, TP | 1 |
| Brunet, R; Bui, BN; Chauvergne, J; Durand, M; Hoerni, B; Mauriac, L | 1 |
| Bernard, JP; Fournel, P; Jorda, M; Laennec, E; Piperno, D; Rebattu, P; Souquet, PJ; Trillet, V | 1 |
| Abad, A; Ariza, A; Barnadas, A; Carles, J; Fernandez-Vasalo, G; Pellicer, I; Rosell, R; Sanchez, JJ | 1 |
| Barduagni, M; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
| Boni, C; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
| Gohma, I; Inoue, T; Kobashi, Y; Kohri, Y; Matsumura, Y; Mino, M; Oida, K; Taguchi, Y; Takano, Y; Tomii, K | 1 |
| Ando, M; Eguchi, K; Katsumata, N; Maeda, M; Ohe, Y; Oshita, F; Shinkai, T; Shiraishi, J; Tamura, T; Yamamoto, N | 1 |
| Alberto, P; Bolla, M; Brambilla, E; Leyvraz, S; Mermillod, B; Mirimanoff, RO; Moro, D; Nagy-Mignotte, H; Wellmann, D | 1 |
| Hirano, S; Iguchi, H; Izumi, H; Matsushita, Y; Takeuchi, T; Tone, H | 1 |
| Hojo, H; Kodama, T; Matsumoto, T; Nagai, K; Nishiwaki, Y; Nishiyama, H | 1 |
| Doi, O; Higashiyama, M; Kodama, K; Kuriyama, K; Yokouchi, H | 1 |
| Arcangeli, G; Marini, G; Marpicati, P; Meriggi, F; Milano, S; Simoncini, E; Zaniboni, A | 1 |
| Bando, H; Doi, H; Kimura, K; Kobayashi, M; Nakayama, T; Ogura, T; Sasaki, H; Shimizu, E; Sone, S; Takishita, Y | 1 |
| Bains, MS; Burt, ME; Flehinger, BJ; Gralla, RJ; Heelan, R; Kris, MG; Martini, N; McCormack, PM; Pisters, KM; Rigas, JR | 1 |
| Artal, A; Barón, JM; Berrocal, A; Feliu, J; García Girón, C; Garrido, P; González Barón, M; Ordóñez, A | 1 |
| Gralla, RJ; Heelan, RT; Kris, MG; Martini, N; Pisters, KM; Zaman, MB | 1 |
| Balmes, P; Bonnaud, F; Carles, P; Guerin, JC; Kleisbauer, JP; Le Caer, H; Perol, M; Poirier, R; Taytard, A; Thomas, P | 1 |
| Higashi, Y; Inoue, K; Kanoh, T; Kurihara, T; Suemasu, K; Tabei, T | 1 |
| Kimura, H; Yamaguchi, Y | 2 |
| Adachi, S; Hasegawa, T; Ishii, N; Katakami, N; Nakai, H; Nakano, K; Takada, Y; Tamura, R; Tsubota, N; Umeda, B | 1 |
| Di Fabio, D; Marini, G; Milano, S; Mombelloni, G; Ottoni, DB; Zaniboni, A; Zorzi, F | 1 |
| Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
| Bonichon, F; Coindre, JM; de Mascarel, I; Durand, M; MacGrogan, G; Mauriac, L; Trojani, M | 1 |
| Airoma, G; Bianco, AR; Cognetti, F; D'Aprile, M; De Placido, S; Gallo, C; Gebbia, V; Gridelli, C; Incoronato, P; Leonardi, V; Natali, M; Palazzolo, G; Palmeri, S; Pepe, R; Perrone, F; Rossi, A; Russo, A; Scinto, AF; Veltri, E | 1 |
| Aguiló, J; García, F; Gómez, A; Grau, E; Ibáñez, JL; Mirabet, MD; Pastor, E; Perella, M | 1 |
| Akira, M; Atagi, S; Furuse, K; Kamimori, T; Kawahara, M; Kodama, N; Kubota, K; Naka, N; Ogawara, M | 1 |
| Li, JH | 1 |
| Buccheri, G; Ferrigno, D | 1 |
| Barriere, JR; Bonnaud, F; Clavier, J; Kleisbauer, JP; Paillotin, D; Pignon, T; Poirier, R; Pommier De Santi, P; Robinet, G; Taytard, A; Thomas, P; Vernenegre, A | 1 |
| Fukuoka, M; Furuse, K; Kawahara, M; Kodama, N; Kubota, K; Kudoh, S; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ogawara, M; Takada, M; Takifuji, N | 1 |
| Masuda, N | 1 |
| Agostara, B; Amoroso, D; Boccardo, F; Farris, A; Gallo, L; Mesiti, M; Pacini, P; Perrotta, A; Rubagotti, A; Sismondi, P; Villa, E | 1 |
| Akusawa, H; Horie, T; Kadota, A; Koya, Y; Masutani, M; Ohchi, Y; Takahashi, N; Tanigawa, S | 1 |
| Chrysanthopoulos, K; Dougenis, D; Ginopoulos, P; Gogos, CH; Kardamakis, D; Onyenadum, A; Solomou, E; Spyropoulos, K | 1 |
| Ashley, S; Hickish, T; Middleton, GW; Norton, A; O'Brien, ME; Priest, K; Smith, IE; Spencer, L | 1 |
| Denis, L | 1 |
| Ichiwata, T; Ishihara, Y; Kuramitsu, K; Ogata, T; Takizawa, T; Uchiyama, T; Yamamoto, M; Yoneda, S; Yoshida, K | 1 |
| Antilli, A; Ardizzoni, A; Baldini, E; Bandera, M; Barbera, S; Borghini, U; Cacciani, GC; Crippa, M; De Marinis, F; Ferrara, G; Fioretti, M; Galeasso, G; Lanfranco, C; Lepidini, G; Migliorino, MR; Noseda, MA; Pennucci, MC; Portalone, L; Raimondi, M; Rinaldi, M; Romano, F; Rosso, R; Salvati, F; Sunseri, G; Tibaldi, C | 1 |
| Hirota, S; Hishikawa, Y; Honda, K; Kono, K; Obayasi, K; Soejima, T; Takada, Y; Watanabe, H | 1 |
| Ciccone, AM; Coloni, GF; De Giacomo, T; Rendina, EA; Ricci, C; Ruvolo, G; Venuta, F | 1 |
| Mikata, A; Mizutani, F; Nakamura, S; Sakao, S; Sasaki, Y; Tada, Y; Takiguchi, Y; Yagi, T; Yamagishi, F | 1 |
| Hitomi, S; Miyahara, R; Tanaka, F; Wada, H | 1 |
| Endo, K; Ichimura, H; Inoue, S | 1 |
| Bains, M; Ginsberg, RJ; Grant, SC; Heelan, RT; Kris, MG; Martini, N; Miller, VA; Ng, KK; Pisters, KM; Rosenzweig, KE; Rusch, V | 1 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Katagami, N; Kawahara, M; Kudoh, S; Nishikawa, H; Takada, Y | 1 |
| Kurano, R; Ono, K; Semba, H; Seto, M; Seto, T | 1 |
| Favalli, G; Pecorelli, S; Renard, J; Van Oosterom, AT; Vantongelen, K; Vermorken, JB | 1 |
| Hirai, H; Kanda, A; Sasaki, H; Suzuki, T; Yanai, M | 1 |
| Aoki, H; Fukai, S; Hashimoto, K; Hayashihara, K; Ishida, T; Kuwahara, K; Minegishi, Y; Nemoto, E; Okano, T; Saito, T; Watanabe, K; Watanabe, S; Yanai, N | 1 |
| Inoue, Y; Ishii, H; Ito, M; Ito, T; Kimino, K; Kishikawa, M; Kohno, S; Nakashima, M; Oka, M | 1 |
| Doddoli, C; Fuentes, P; Giudicelli, R; Papazian, L; Reynaud-Gaubert, M; Thomas, P | 1 |
| Sone, S; Yano, S | 1 |
| Boes, GH; Colombo, N; De Oliveira, CF; Lacave, AJ; Teodorovic, I; van der Burg, ME; Vermorken, JB; Zanetta, G | 1 |
| Babović, N; Elezar, E; Gavrilović, D; Jelić, S; Kovacević, S; Kovcin, V; Mitrović, L; Radosavljević, D; Radulović, S; Tomasević, Z | 1 |
| Liao, M; Lin, Z; Lu, S | 1 |
| Feng, F; Sun, Y; Zhang, X | 1 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Ikegami, H; Kishimoto, S; Kunikane, H; Saijo, N; Watanabe, K | 1 |
| Fujii, T; Furue, H; Ikeda, M; Rikimaru, T; Taguchi, T; Tsukagoshi, S | 1 |
| Akira, M; Atagi, S; Hosoe, S; Kawaguchi, T; Kawahara, M; Mitsuoka, S; Naka, N; Ogawara, M; Okishio, K; Sunami, T | 1 |
| Hosomi, Y; Shibuya, M | 1 |
| Borsellino, N; Caruso, M; Colucci, G; Durini, E; Galetta, D; Gebbia, N; Gebbia, V; Gridelli, C; Pezzella, G; Riccardi, F; Valdesi, M; Valenza, R | 1 |
| Beuzeboc, P; Chauveinc, L; Clough, KB; Cosset, JM; de la Rochefordière, A; Guyonnet, M; Mouret-Fourme, E; Nguyen, D | 1 |
| Hayashi, E; Huang, CL; Kameyama, K; Liu, D; Okamoto, T; Yamamoto, Y; Yokomise, H | 1 |
| Fujimura, T; Fushida, S; Kinami, S; Miwa, K; Miyamoto, K; Nao, F; Ninomiya, I; Nishimura, G; Ohta, T; Yokogawa, K | 1 |
| Liu, SJ; Qiang, E; Wang, SP; Yiao, J | 1 |
| Ruffié, P | 1 |
| Mornex, F | 1 |
| Gong, LY; Jiang, CM; Pang, MR | 1 |
| Fukuyama, Y; Ichinose, Y; Yamaguchi, M | 1 |
| Bilkei-Gorzo, A; Michel, K; Palkovits, M; Racz, I; Toth, ZE; Zimmer, A | 1 |
| Clerici, M; Cognetti, F; Crinò, L; Fossati, R; Giaccone, G; Martelli, M; Scagliotti, GV; Silvano, G; Tonato, M; Torri, V | 1 |
| Asamoto, H; Ishiguro, T; Kawahara, M; Maeda, H; Ogawara, M; Sawa, T; Yamamoto, S; Yokota, S; Yoshida, T | 1 |
| Benedicic, Ch; Petru, E; Pickel, H; Seewann, A | 1 |
| Du, GZ; Gao, JF; Li, CS; Ou, WL; Wang, J; Yang, B; Zhang, BC; Zhang, XH; Zhu, YZ | 1 |
| Amadori, S; Anak, O; Beeldens, F; De Witte, T; Denzlinger, C; Fabris, P; Hagemeijer, A; Ho, A; Leone, G; Mandelli, F; Muus, P; Selleslag, D; Stauder, R; Suciu, S; Vignetti, M; Willemze, R | 1 |
| Girling, DJ; Hopwood, P; Stephens, RJ; Thatcher, N | 1 |
| Ichinose, Y; Okamoto, T | 1 |
| Asamura, H; Kodama, T; Kunitoh, H; Matsuno, Y; Ohe, Y; Saijo, N; Sekine, I; Takei, H; Tamura, T; Tsuchiya, R; Yamamoto, N; Yamazaki, S | 1 |
| Funakoshi, Y; Kadota, Y; Kawamura, S; Koma, M; Maeda, H; Matsubara, Y; Takeda, S | 1 |
| Coens, C; Kobierska, A; Lhomme, C; Namer, M; van der Burg, ME; van Luijk, IF; Vermorken, JB; Zanetta, G; Zola, P | 1 |
| Huang, G; Lartigau, E; Shi, D; Shi, G; Zhang, J | 1 |
| Chen, P; Dai, CH; Li, J; Li, XQ; Shi, SB; Wu, JR; Yu, LC | 1 |
| He, YP; Liu, ZH; Qin, H; Zhang, P; Zhou, Y | 1 |
| Harita, S; Hiraki, A; Hiraki, S; Hotta, K; Kamei, H; Kanazawa, S; Kiura, K; Matsuo, K; Nogami, N; Segawa, Y; Shibayama, T; Sugimoto, K; Tabata, M; Takata, I; Takemoto, M; Takigawa, N; Tanimoto, M; Ueoka, H; Watanabe, Y; Yonei, T | 1 |
| Chiba, Y; Fukuoka, M; Hida, T; Imamura, F; Iwamoto, Y; Katakami, N; Kawahara, M; Kudo, S; Nakagawa, K; Nishimura, Y; Saka, H; Satouchi, M; Sawa, T; Semba, H; Seto, T; Takeda, K; Tsujino, K; Uejima, H; Yamamoto, N; Yokota, S | 1 |
| He, YP; Liu, ZH; Ma, YL; Qin, H; Zhang, P; Zhou, YK | 1 |
| Gemba, K; Horita, N; Hotta, K; Kanazawa, S; Kiura, K; Matsuo, K; Moritaka, T; Nagata, T; Okimoto, N; Segawa, Y; Shinkai, T; Tabata, M; Takeda, H; Takemoto, M; Takigawa, N; Tamaoki, A; Tanimoto, M; Tokuda, Y; Ueoka, H; Watanabe, K | 1 |
| Inoue, T; Tateishi, U; Terauchi, T; Torii, I | 1 |
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
12 review(s) available for mitomycin and vindesine
| Article | Year |
|---|---|
[A study of VMMC protocol (vindesine, mitoxantrone, mitomycin C) as a salvage chemotherapy in advanced breast cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Prognosis; Salvage Therapy; Vindesine | 1992 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Remission Induction; Survival Rate; Vindesine | 1990 |
The design of cytotoxic-agent-antibody conjugates.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Bleomycin; Chlorambucil; Humans; Immunotoxins; Mitomycin; Mitomycins; Naphthacenes; Neoplasms; Protein Binding; Radioisotopes; Species Specificity; Structure-Activity Relationship; Vindesine; Zinostatin | 1987 |
Chemotherapy of non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Tolerance; Etoposide; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Vindesine | 1985 |
Chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lomustine; Methotrexate; Mitoguazone; Mitomycin; Mitomycins; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Vinblastine; Vindesine | 1984 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
[Combination chemotherapy in the treatment of inoperable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 1997 |
A solitary bronchial papilloma with malignant changes.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Contraindications; Disease Progression; Electrosurgery; Humans; Keratins; Male; Mitomycin; Neoplasm Proteins; Papilloma; Parkinson Disease, Secondary; Pneumonectomy; Pulmonary Atelectasis; Serpins; Tomography, X-Ray Computed; Vindesine | 2001 |
[ Early anti-cancer drugs].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Vinblastine; Vindesine | 2002 |
[Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Pneumonectomy; Radiotherapy, Adjuvant; Vindesine | 2003 |
Palliative cytostatic treatment of cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Irinotecan; Mitomycin; Paclitaxel; Palliative Care; Randomized Controlled Trials as Topic; Survival Analysis; Uterine Cervical Neoplasms; Vindesine | 2003 |
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Pneumonectomy; Postoperative Care; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vinblastine; Vindesine; Vinorelbine | 2005 |
72 trial(s) available for mitomycin and vindesine
| Article | Year |
|---|---|
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neutropenia; Time Factors; Vindesine | 1992 |
[Role of neoadjuvant chemotherapy in the treatment of advanced head and neck tumors. Results of two randomized therapeutical trials conducted at the Institut Curie on 208 patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Vindesine | 1992 |
Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Survival Analysis; Vindesine | 1992 |
[A study of VMMC protocol (vindesine, mitoxantrone, mitomycin C) as a salvage chemotherapy in advanced breast cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Prognosis; Salvage Therapy; Vindesine | 1992 |
Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Thiotepa; Vincristine; Vindesine | 1992 |
A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate; Vindesine | 1991 |
Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Peplomycin; Ploidies; Prognosis; Vindesine | 1991 |
Phase III trial with and without lonidamine in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Prospective Studies; Remission Induction; Survival Rate; Time Factors; Vindesine | 1991 |
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Protocols; Epirubicin; Female; Humans; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Thiotepa; Vincristine; Vindesine | 1991 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Remission Induction; Survival Rate; Vindesine | 1990 |
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Regression Analysis; Remission Induction; Sex Factors; Survival Rate; Vindesine | 1990 |
[Current results of chemotherapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Survival Rate; Vindesine | 1990 |
[Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Prospective Studies; Randomized Controlled Trials as Topic; Vindesine | 1990 |
Vindesine and mitomycin C in metastatic breast cancer. A Southeastern Cancer Study Group Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Vindesine | 1989 |
[A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Random Allocation; Vindesine | 1987 |
High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Vindesine | 1988 |
[Chemotherapy of breast cancers. Coordinated evolution of therapeutic schemes from 1975 to 1985].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Thiotepa; Vincristine; Vindesine | 1986 |
Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Mitomycins; Prospective Studies; Random Allocation; Vindesine | 1986 |
[Restorative effect of muroctasin, MDP-Lys (L 18), on leukopenia caused by anticancer chemotherapy in lung cancer--comparative study by envelope method].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Vincristine; Vindesine | 1988 |
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Random Allocation; Vinblastine; Vindesine | 1986 |
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Vindesine | 1986 |
Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Clinical Trials as Topic; Follow-Up Studies; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasm Metastasis; Vindesine | 1986 |
Treatment of prostatic cancer: the EORTC experience--preliminary results of prostatic carcinoma trials.
Topics: Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Procarbazine; Prostatic Neoplasms; Random Allocation; Vinblastine; Vindesine | 1984 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Platinum; Vindesine | 1993 |
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Survival Rate; Treatment Outcome; Vindesine | 1995 |
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Retrospective Studies; Survival Rate; Vindesine | 1995 |
Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncologie Th
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Radiotherapy; Survival Rate; Treatment Failure; Vindesine | 1995 |
[A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pilot Projects; Vindesine | 1993 |
MICE: a new active combination for non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Vindesine | 1993 |
Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Survival Analysis; Vindesine | 1993 |
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Survival Analysis; Vindesine | 1993 |
Cisplatin-mitomycin and vindesine in the treatment of inoperable non-small cell lung cancer groupe français de pneumo-cancérologie (GFPC)
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prospective Studies; Vindesine | 1993 |
Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diaphragm; Female; Humans; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Pleural Neoplasms; Prognosis; Vindesine | 1995 |
[Effect of timing of granulocyte-colony stimulating factor administration on leukopenia induced by systemic chemotherapy in patients with non-small-cell lung cancer--multi-center randomized crossover study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cross-Over Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Mitomycin; Time Factors; Vindesine | 1996 |
Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Prospective Studies; Vindesine | 1996 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.
Topics: Adult; Aged; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Epirubicin; Female; Glutathione Transferase; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Mitomycin; Neoplasm Proteins; Prognosis; Proteins; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Thiotepa; Trefoil Factor-1; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Vincristine; Vindesine | 1996 |
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Survival Rate; Treatment Outcome; Vindesine | 1996 |
[A study on treatment of lung cancer by combined therapy of traditional Chinese medicine and chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Diagnosis, Differential; Drugs, Chinese Herbal; Etoposide; Female; Humans; Lung Neoplasms; Male; Medicine, Chinese Traditional; Middle Aged; Mitomycin; Survival Rate; Vindesine | 1996 |
Efficacy of platinum-based regimens in non-small cell lung cancer. A negative report from the Cuneo Lung Cancer Study Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Quality of Life; Vindesine | 1997 |
Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Radiation-Sensitizing Agents; Vinblastine; Vindesine; Vinorelbine | 1997 |
Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Neoplasms; Mitomycin; Retrospective Studies; Vindesine | 1997 |
Lack of effectiveness of adjuvant alternating chemotherapy in node-positive, estrogen-receptor-negative premenopausal breast cancer patients: results of a multicentric Italian study. The Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group (GROC
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Premenopause; Receptors, Estrogen; Survival Analysis; Vincristine; Vindesine | 1997 |
A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancer.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine | 1996 |
Advanced non-small cell lung cancer chemotherapy: a randomized trial of two active regimens (MVP and PE).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Treatment Outcome; Vindesine | 1997 |
Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Mitomycin; Multivariate Analysis; Palliative Care; Survival Rate; Treatment Outcome; Vindesine | 1998 |
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
[Comparative study on quality of life between weekly and monthly chemotherapy with cisplatin, vindesine and mitomycin C in patients with non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Vindesine | 1998 |
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vinblastine; Vindesine | 1998 |
Induction chemotherapy for T4 centrally located non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pneumonectomy; Preoperative Care; Prospective Studies; Vindesine | 1999 |
Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Postoperative Period; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vindesine | 1999 |
[Anti-emetic treatment for patients with non-small cell lung cancer after chemotherapy, usefulness of preventive combination of anti-emetic agents and importance of psychiatric aspect of patients].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Lung Neoplasms; Male; Methylprednisolone; Metoclopramide; Middle Aged; Mitomycin; Personality; Vindesine; Vomiting, Anticipatory | 1999 |
Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Survival Rate; Vinblastine; Vindesine | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Prospective Studies; Recurrence; Survival Analysis; Vindesine | 1999 |
Quality control in multicentric clinical trials. An experience of the EORTC Gynecological Cancer Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Data Collection; Female; Humans; Mitomycin; Quality Control; Uterine Cervical Neoplasms; Vindesine | 2000 |
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Europe; Female; Humans; Middle Aged; Mitomycin; Prospective Studies; Survival Analysis; Treatment Outcome; Uterine Neoplasms; Vindesine | 2001 |
Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; Vindesine | 2001 |
Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Drug Administration Schedule; Erythropoietin; Female; Hemoglobins; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Recombinant Proteins; Treatment Outcome; Vindesine | 2001 |
[Clinical usefulness of ondansetron injection in patients receiving cancer chemotherapy].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Ondansetron; Ovarian Neoplasms; Retrospective Studies; Vindesine | 2002 |
A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiation Dosage; Survival Rate; Treatment Failure; Vindesine | 2002 |
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2002 |
[Comparison of NP and MVP regimen in treatment of advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Treatment Outcome; Vincristine; Vindesine | 2002 |
[Clinical observation on effect of chemotherapy combined with Chinese medicine in treating advanced tumor patients and on immunologic parameters].
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Cisplatin; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Killer Cells, Natural; Lung Neoplasms; Male; Middle Aged; Mitomycin; Phytotherapy; Stomach Neoplasms; Vindesine | 2001 |
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Patient Compliance; Patient Selection; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome; Vindesine | 2003 |
[Prospective randomized study of HMVP, MVP, and HVP regimens in treatment of advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prospective Studies; Vindesine | 2004 |
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.
Topics: Acute Disease; Aged; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Gemtuzumab; Humans; Ifosfamide; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Mitomycin; Reproducibility of Results; Survival Analysis; Vindesine | 2004 |
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Radiotherapy; Time Factors; Treatment Outcome; Vindesine | 2005 |
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Humans; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Vindesine | 2007 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Taxoids; Vindesine | 2010 |
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Radiotherapy, Adjuvant; Vindesine | 2010 |
Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Japan; Lung Neoplasms; Male; Mitomycin; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vindesine | 2011 |
83 other study(ies) available for mitomycin and vindesine
| Article | Year |
|---|---|
Mitomycin C and vindesine: an ineffective combination chemotherapy in the treatment of malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Male; Mesothelioma; Middle Aged; Mitomycin; Pleural Neoplasms; Treatment Outcome; Vindesine | 1992 |
[Evaluation of chemotherapy of unresectable non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vindesine | 1992 |
[Advances in the treatment of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Vindesine | 1992 |
Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vindesine | 1992 |
Pharmacokinetic study of mitomycin C with emphasis on the influence of aging.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Uterine Cervical Neoplasms; Vindesine | 1992 |
Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Hypokalemia; Hyponatremia; Kidney Diseases; Lung Neoplasms; Magnesium; Male; Middle Aged; Mitomycin; Vindesine; Water-Electrolyte Imbalance | 1992 |
Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Palliative Care; Survival Rate; Treatment Outcome; Vindesine | 1992 |
The role of three cisplatin-based chemotherapy regimens in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies; Vincristine; Vindesine | 1992 |
[Chemotherapy-associated hemolytic uremic syndrome--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Esophageal Neoplasms; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Stomach Neoplasms; Vindesine | 1992 |
Necrotizing bronchial aspergillosis in a patient receiving neoadjuvant chemotherapy for non-small cell lung carcinoma.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Bronchi; Bronchial Diseases; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Itraconazole; Ketoconazole; Lung Neoplasms; Mitomycin; Mitomycins; Necrosis; Vindesine | 1991 |
[Assessment of a phase III trial of adjuvant chemotherapy in resected lung cancer: an imbalance of surgical results among cooperative institutions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Multicenter Studies as Topic; Survival Rate; Vindesine | 1991 |
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Mitomycin; Neoplasm Staging; Remission Induction; Time Factors; Vindesine | 1991 |
Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Melphalan; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Palliative Care; Vindesine | 1991 |
[The relation between myelotoxicity and performance status or aging in chemotherapy of non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Thrombocytopenia; Vindesine | 1991 |
[Clinical evaluation of bronchial artery infusion (BAI) in lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Cisplatin; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Retrospective Studies; Survival Rate; Vindesine | 1991 |
[Thymic undifferentiated carcinoma with resection of superior vena cava: report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Female; Humans; Mitomycin; Mitomycins; Thymus Neoplasms; Vena Cava, Superior; Vindesine | 1991 |
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms, Unknown Primary; Prognosis; Remission Induction; Survival Rate; Vindesine | 1990 |
[Interstitial pneumonia developed after combination chemotherapy with (CDDP, VDS, MMC) and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Male; Mitomycin; Mitomycins; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy; Vindesine | 1990 |
[Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Vindesine | 1990 |
[Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Survival Rate; Thrombocytopenia; Vindesine | 1990 |
[Combination chemotherapy with cis-diamminedichloroplatinum (CDDP) and other anticancer agents for patients with advanced esophageal cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Nausea; Peplomycin; Vinblastine; Vindesine; Vomiting | 1985 |
[Current perspectives in the management of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Vinblastine; Vincristine; Vindesine | 1985 |
[Characterization of chromosomal aberrations induced in man by various antimitotic agents].
Topics: Antineoplastic Agents; Benzopyrans; Bleomycin; Cells, Cultured; Chromosome Aberrations; Cisplatin; Humans; Karyotyping; Lymphocytes; Mitomycin; Mitomycins; Mitosis; Structure-Activity Relationship; Teniposide; Vindesine | 1985 |
Preliminary results of preoperative chemotherapy with a combination of platinum-bleomycin administered in 5-day cycles in carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Platinum; Postoperative Complications; Vindesine | 1986 |
[Analysis of the chemosensitivity test by subrenal capsule assay].
Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Colonic Neoplasms; Colony-Forming Units Assay; Doxorubicin; Esophageal Neoplasms; Humans; Mice; Mitomycin; Mitomycins; Peplomycin; Rectal Neoplasms; Stomach Neoplasms; Tumor Stem Cell Assay; Vindesine | 1987 |
[Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Peplomycin; Vindesine | 1988 |
[Bronchial arterial infusion chemotherapy (BAI) and BAI with radiotherapy in advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Peplomycin; Radiotherapy Dosage; Vindesine | 1988 |
Treatment of testicular tumors: analysis of treatment results of chemotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Dysgerminoma; Humans; Male; Mitomycin; Mitomycins; Teratoma; Testicular Neoplasms; Time Factors; Vindesine | 1988 |
[Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Vindesine | 1989 |
[Effect of the pulmonary artery infusion chemotherapy of non-small cel lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Pulmonary Artery; Vindesine | 1989 |
[Combination chemotherapy with bronchial arterial infusion (BAI) and systemic chemotherapy in advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Vindesine | 1989 |
Serial measurement of sister chromatid exchanges in the peripheral lymphocytes of patients with lung cancer receiving chemotherapy in relation to bone marrow toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Lymphocytes; Mitomycin; Mitomycins; Sister Chromatid Exchange; Vincristine; Vindesine | 1989 |
The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Mitomycin; Mitomycins; Radiography; Vinblastine; Vindesine | 1988 |
[Prolonged remissions induced by the combination vindesine, mitoxantrone, mitomycine C in metastatic breast cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Neoplasm Metastasis; Time Factors; Vindesine | 1987 |
[Combination chemotherapy with 3 or 4 drugs on human breast and gastrointestinal cancer xenografts in nude mice (II)].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Female; Floxuridine; Fluorouracil; Humans; Methotrexate; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Vindesine | 1987 |
[Effects of alternating chemotherapy with 2 non-cross-resistant drug combinations on human alimentary and breast cancer xenografts in nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Male; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Pancreatic Neoplasms; Vindesine | 1987 |
Vindesine and mitomycin C in chemotherapy: refractory advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Leukopenia; Menopause; Middle Aged; Mitomycin; Mitomycins; Nausea; Neoplasm Metastasis; Neoplasm Staging; Peripheral Nervous System Diseases; Vindesine | 1986 |
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Vindesine | 1985 |
[Chemotherapy of non-small cell bronchial cancer with mitomycin C, vindesine and cisplatin. Results of a phase II study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Vindesine | 1987 |
[Antiemetic treatment with metoclopramide and high-dose lorazepam and additional long-term treatment with lorazepam during CDDP administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Mitomycin; Mitomycins; Vindesine; Vomiting, Anticipatory | 1988 |
Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Humans; Lung Diseases, Obstructive; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Vinblastine; Vindesine | 1985 |
Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytotoxicity Tests, Immunologic; Doxorubicin; Etoposide; Female; Humans; Immune Tolerance; In Vitro Techniques; Killer Cells, Natural; Lung Neoplasms; Male; Mediastinal Neoplasms; Methylprednisolone; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Vinblastine; Vindesine | 1985 |
EORTC Phase II chemotherapy studies in prostate cancer.
Topics: Drug Evaluation; Humans; Male; Mitomycin; Mitomycins; Prostatic Neoplasms; Vinblastine; Vindesine | 1985 |
[The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carbazilquinone; Carcinoembryonic Antigen; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Peplomycin; Vinblastine; Vincristine; Vindesine | 1984 |
[Platelet aggregation and coenzyme Q10 content in platelets in cancer patients].
Topics: Adult; Aged; beta-Thromboglobulin; Blood Platelets; Chromatography, High Pressure Liquid; Coenzymes; Collagen; Epinephrine; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Platelet Aggregation; Platelet Count; Ubiquinone; Vinblastine; Vindesine | 1984 |
Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Resistance; Female; Humans; Leukopenia; Middle Aged; Mitomycin; Mitomycins; Pneumonia; Thrombocytopenia; Vinblastine; Vindesine | 1983 |
[Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Thiotepa; Vinblastine; Vindesine | 1981 |
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; CD57 Antigens; Cell Differentiation; Chromogranin A; Chromogranins; Cisplatin; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Immunologic Factors; Interferons; Karnofsky Performance Status; Life Tables; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Proteins; Neoplasm Staging; Phosphopyruvate Hydratase; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Survival Rate; Synaptophysin; Vindesine | 1993 |
[A case of lung cancer with choroidal metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Choroid Neoplasms; Cisplatin; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Mitomycin; Vindesine | 1995 |
The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function.
Topics: Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Regression Analysis; Vindesine | 1995 |
Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Leukemia P388; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Mitomycin; Peplomycin; Vindesine | 1994 |
Lung cancer found in a patient with absence of the inferior vena cava associated with a left superior vena cava.
Topics: Aged; Angiography, Digital Subtraction; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Congenital Abnormalities; Humans; Lung Neoplasms; Lymph Node Excision; Male; Mitomycin; Pneumonectomy; Tomography, X-Ray Computed; Venae Cavae; Vindesine | 1994 |
Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Pneumonectomy; Survival Rate; Time Factors; Vinblastine; Vindesine | 1993 |
Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine | 1993 |
[Usefulness of contact thermography for the evaluation of chemotherapeutic effectiveness in breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Floxuridine; Humans; Methotrexate; Middle Aged; Mitomycin; Thermography; Vindesine | 1993 |
Histopathological grading of response to induction chemotherapy in non-small cell lung cancer: a preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Vindesine | 1996 |
[Diagnosis and therapeutic management of gastric lymphomas].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gastrectomy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitomycin; Prednisone; Radioisotope Teletherapy; Remission Induction; Retrospective Studies; Spain; Stomach Neoplasms; Treatment Outcome; Vincristine; Vindesine | 1996 |
A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neurologic Examination; Pilot Projects; Prognosis; Regression Analysis; Severity of Illness Index; Survival Rate; Vindesine | 1997 |
[Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophagitis; Esophagoscopy; Etoposide; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Radiation Injuries; Radiotherapy; Vindesine | 1998 |
[A case of thymic carcinoma producing granulocyte colony-stimulating factor].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Male; Mitomycin; Thymus Neoplasms; Treatment Outcome; Vindesine | 1998 |
[A long-term survivor of extensive-stage small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Survivors; Vindesine | 2000 |
Chemotherapy for older people with non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Comorbidity; Female; Hospitalization; Humans; Lung Neoplasms; Male; Mitomycin; Prospective Studies; Survival Analysis; Vindesine | 2000 |
[Effectiveness of docetaxel plus cisplatin in large cell lung cancer showing little response to prior chemotherapy with MVP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Failure; Vindesine | 2000 |
[Postoperative complications after radiochemotherapy or chemotherapy for bronchial cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Fistula; Carcinoma, Bronchogenic; Cause of Death; Cisplatin; Etoposide; Female; Fluorouracil; Hospital Mortality; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pneumonectomy; Pneumonia; Radiotherapy, Adjuvant; Reoperation; Retrospective Studies; Risk Factors; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2000 |
[Treatment for elderly lung cancer patients by anticancer drugs and possible use of target based drugs].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Vindesine | 2001 |
[A comparative study between clinical response and pathologic changes to preoperative chemotherapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vindesine | 1999 |
[Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Vindesine | 1999 |
[Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Paris; Prognosis; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Vindesine | 2002 |
Induction chemotherapy before operation for multiple endobronchial squamous cell carcinoma of the lung.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Treatment Outcome; Vindesine | 2002 |
[Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Vindesine | 2002 |
[New therapeutic options for mesothelioma].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Doxorubicin; Folic Acid Antagonists; France; Gemcitabine; Humans; Mesothelioma; Mitomycin; Neoplasm Staging; Patient Selection; Pneumonectomy; Prognosis; Quinazolines; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis; Thiophenes; Treatment Outcome; Vindesine | 2002 |
[Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Mitomycin; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2002 |
A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking.
Topics: Alcohol Drinking; Alcoholism; Animals; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Behavior, Animal; Choice Behavior; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Electroshock; Ethanol; Hypothermia; Ifosfamide; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitomycin; Motor Activity; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Receptors, Drug; Stress, Physiological; Substance Withdrawal Syndrome; Vindesine | 2003 |
[Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Postoperative Period; Radiotherapy Dosage; Retrospective Studies; Vindesine | 2003 |
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Treatment Outcome; Vindesine | 2005 |
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Empyema, Pleural; Female; Forced Expiratory Volume; Forecasting; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Pneumonia; Postoperative Complications; Predictive Value of Tests; Pulmonary Atelectasis; Pulmonary Diffusing Capacity; Pulmonary Embolism; Pulmonary Gas Exchange; Radiotherapy; Remission Induction; Respiratory Distress Syndrome; Respiratory Insufficiency; Retrospective Studies; Risk Factors; Vinblastine; Vindesine; Vinorelbine; Vital Capacity | 2006 |
Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Calcium Channel Blockers; Cell Proliferation; Cisplatin; Dose Fractionation, Radiation; Doxorubicin; Drug Resistance, Neoplasm; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Radiation Tolerance; Spheroids, Cellular; Tumor Cells, Cultured; Verapamil; Vindesine; X-Rays | 2009 |
Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiotherapy; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine | 2009 |
Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Cycle; Cell Line, Tumor; Cholangiocarcinoma; Doxorubicin; Drug Resistance, Multiple; Humans; Mitomycin; Vindesine | 2011 |
Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cholangiocarcinoma; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Intracellular Space; Mitomycin; RNA, Messenger; Tamoxifen; Vindesine | 2011 |
Prognostic implications of diffusion-weighted magnetic resonance imaging in patients with superior sulcus tumors receiving induction chemoradiation therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Humans; Induction Chemotherapy; Infusions, Intravenous; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Prognosis; Thoracotomy; Tomography, X-Ray Computed; Treatment Outcome; Vindesine | 2016 |
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |